Marco Donia

Has grant

Copenhagen University Hospital

Denmark

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Comprehensive Functional Profiling of Tumor-infiltrating Lymphocytes (CO-FU-TILs)

Open Date: 2018-01-01

Close Date: 2018-12-31

Grant: Close

Antitumor Responses in T-cell Immunotherapy for Ovarian Cancer (ARTIOC)

Open Date: 2015-01-01

Close Date: 2015-12-31

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (11)

Giulia Franciosa

Københavns Universitet

DENMARK

View details

Nikolaj Pagh Kristensen

University Hospital Erlangen

GERMANY

View details

Özcan Met

Københavns Universitet

DENMARK

View details

Jesper Olsen

Professor

University of Copenhagen

DENMARK

View details

Geke Hospers

Professor of Medical Oncology

University Medical Center Groningen

NETHERLANDS

View details

Mads Hald Andersen

Professor, dr.techn., Director

DENMARK

View details

Sine Reker Hadrup

Technical University of Denmark

DENMARK

View details

Jacob Bjerrum

Consultant Gastroenterologist and Associate Professor

Herlev Hospital

DENMARK

View details

Inge Marie Svane

Københavns Universitet

DENMARK

View details

Ellen H. W. Kapiteijn

Leiden University Medical Center

NETHERLANDS

View details

Per thor Straten

Københavns Universitet

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Marco Donia

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (11)

of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes

First in man study

Uncoupling CD4+ TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

Uncoupling CD4+ TIL-mediated tumor killing from JAK-signaling in melanoma.

Letter: be careful of gastrointestinal CMV infection in adverse event from ICIs therapy in solid tumours-Authors' reply.

Proteomics to study cancer immunity and improve treatment

TIL Therapy: Facts and Hopes

Intratumoral T-cell and B-cell receptor architecture associates with distinct immune tumor microenvironment features and clinical outcomes of anti-PD-1/L1 immunotherapy

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma

Editorial: safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor-induced colitis-authors' reply.

Phase 2 study of ipilimumab, nivolumab, and tocilizumab combined with stereotactic body radiotherapy in patients with refractory pancreatic cancer (TRIPLE-R).

Collaborators (11)

Giulia Franciosa

Nikolaj Pagh Kristensen

Özcan Met

Jesper Olsen

Geke Hospers

Mads Hald Andersen

Sine Reker Hadrup

Jacob Bjerrum

Inge Marie Svane

Ellen H. W. Kapiteijn

Per thor Straten

Make your next move.